Fms-related tyrosine kinase 3 ligand promotes proliferation of placenta amnion and chorion mesenchymal stem cells in vitro

Li,Fang; Xu,Yunyun; Xu,Xiaoxia; Xu,Biao; Zhao,Juan; Zhang,Xueguang

doi:10.3892/mmr.2014.2220

Fms-related tyrosine kinase 3 ligand promotes proliferation of placenta amnion and chorion mesenchymal stem cells in vitro

Authors:
- Fang Li
- Yunyun Xu
- Xiaoxia Xu
- Biao Xu
- Juan Zhao
- Xueguang Zhang
View Affiliations

Affiliations: Institute of Medical Biotechnology, Soochow University, Jiangsu Key Laboratory of Stem Cells, Suzhou, Jiangsu 215007, P.R. China, Institute of Medical Biotechnology, Soochow University, Jiangsu Key Laboratory of Stem Cells, Suzhou, Jiangsu 215007, P.R. China
Published online on: May 8, 2014 https://doi.org/10.3892/mmr.2014.2220
Pages: 322-328

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Placental mesenchymal stem cells (PMSCs) have important biological properties and the potential for application in numerous clinical fields, including hematopoietic stem cell transplantation and myocardial repair. There are two types of MSCs in the placenta, amniotic mesenchymal stem cells (AMSCs) and chorion mesenchymal stem cells (CMSCs). By comparing the biological characteristics of human placental AMSCs with CMSCs, the present study identified that CD90‑ and CD166‑positive cells were located in the amniotic stroma and chorion stroma surrounding the vessels. In addition, the cultured AMSCs and CMSCs expressed high levels of CD73, CD90, CD105, CD29 and CD44; however they did not express CD14, CD34, CD45 and HLA-DR. Furthermore, the amplification of the fms-related tyrosine kinase 3 ligand (FL) in AMSCs and CMSCs was investigated in vitro. The results demonstrated that FL is able to promote the proliferation of AMSCs and CMSCs effectively in vitro, particularly that of CMSCs. In the FL group, the phenotype and the ability of AMSCs and CMSCs to differentiate into mesenchymal lineages did not change. Flt3, the receptor of FL, is expressed in AMSCs and CMSCs. In conclusion, mesenchymal stem cells with low immunogenicity were identified in the placental amniotic membrane and around the chorion axis. Furthermore, FL has a positive effect on the proliferation of AMSCs and CMSCs in vitro; however, does not affect their differentiation potential. It is particularly promising that FL is able to stimulate CMSCs to proliferate in vitro.

View Figures

View References

1	Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
2	Rao MS and Mattson MP: Stem cells and aging: expanding the possibilities. Mech Ageing Dev. 122:713–734. 2001. View Article : Google Scholar : PubMed/NCBI
3	Fernández M, Simon V, Herrera G, Cao C, Del Favero H and Minguell JJ: Detection of stromal cells in peripheral blood progenitor cell collections from breast cancer patients. Bone Marrow Transplant. 20:265–271. 1997.PubMed/NCBI
4	Erices A, Conget P and Minguell JJ: Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 109:235–242. 2000. View Article : Google Scholar : PubMed/NCBI
5	Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL and Chen TH: Isolation of multi-potent mesenchymal stem cells from umbilical cord blood. Blood. 103:1669–1675. 2004. View Article : Google Scholar : PubMed/NCBI
6	Miura M, Gronthos S, Zhao M, Lu B, Fisher LW, Robey PG and Shi S: SHED: stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci USA. 100:5807–5812. 2003. View Article : Google Scholar : PubMed/NCBI
7	Romanov YA, Svintsitskaya VA and Smirnov VN: Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells. 21:105–110. 2003.PubMed/NCBI
8	Yen BL, Huang HI, Chien CC, Jui HY, Ko BS, Yao M, Shun CT, Yen ML, Lee MC and Chen YC: Isolation of multipotent cells from human term placenta. Stem Cells. 23:3–9. 2005. View Article : Google Scholar : PubMed/NCBI
9	Goodwin HS, Bicknese AR, Chien SN, Bogucki BD, Quinn CO and Wall DA: Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers. Biol Blood Marrow Transplant. 7:581–588. 2001. View Article : Google Scholar : PubMed/NCBI
10	Parolini O, Alviano F, Bagnara GP, et al: Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells. 26:300–311. 2008. View Article : Google Scholar : PubMed/NCBI
11	Fukuchi Y, Nakajima H, Sugiyama D, Hirose I, Kitamura T and Tsuji K: Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem cells. 22:649–658. 2004. View Article : Google Scholar : PubMed/NCBI
12	Gilliland DG and Griffin JD: The roles of FLT3 in hematopoiesis and leukemia. Blood. 100:1532–1542. 2002. View Article : Google Scholar : PubMed/NCBI
13	Rosnet O and Birnbaum D: Hematopoietic receptors of class III receptor-type tyrosine kinases. Crit Rev Oncog. 4:595–613. 1993.PubMed/NCBI
14	Agnès F, Shamoon B, Dina C, Rosnet O, Birnbaum D and Galibert F: Genomic structure of the downstream part of the human FLT3 gene:exon/intron structure conservation among genes encoding receptor tyrosine kinases (RTK) of subclass III. Gene. 145:283–288. 1994.PubMed/NCBI
15	deLapeyrière O, Naquet P, Planche J, Marchetto S, Rottapel R, Gambarelli D, Rosnet O and Birnbaum D: Expression of Flt3 tyrosine kinase receptor gene in mouse hematopoietic and nervous tissues. Differentiation. 58:351–359. 1995.PubMed/NCBI
16	Maroc N, Rottapel R, Rosnet O, Marchetto S, Lavezzi C, Mannoni P, Birnbaum D and Dubreuil P: Biochemical characterization and analysis of the transform ing potential of the FLT3/FLK2 receptor tyrosine kinase. Oncogene. 8:909–918. 1993.PubMed/NCBI
17	Rottapel R, Turck CW, Casteran N, Liu X, Birnbaum D, Pawson T and Dubreuil P: Substrate specificities and identification of a putative binding site for PI3K in the carboxy tail of the murine Flt3 receptor tyrosine kinase. Oncogene. 9:1755–1765. 1994.PubMed/NCBI
18	Li F, Miao ZN, Xu YY, Zheng SY, Qin MD, Gu YZ and Zhang XG: Transplantation of human amniotic mesenchymal stem cells in the treatment of focal cerebral ischemia. Mol Med Report. 6:625–630. 2012.PubMed/NCBI
19	Gatti S, Bruno S, Deregibus MC, Sordi A, Cantaluppi V, Tetta C and Camussi G: Microvesicles derived from human adult mesenchymal stem cells protect against ischemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant. 26:1474–1483. 2011. View Article : Google Scholar
20	Lai RC, Arslan F, Lee MM, et al: Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 4:214–222. 2010. View Article : Google Scholar : PubMed/NCBI
21	Bruno S, Grange C, Deregibus MC, et al: Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol. 20:1053–1067. 2009. View Article : Google Scholar : PubMed/NCBI
22	Schweitzer KS, Johnstone BH, Garrison J, et al: Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking. Am J Respir Crit Care Med. 183:215–225. 2011. View Article : Google Scholar : PubMed/NCBI
23	Herrera MB, Fonsato V, Gatti S, Deregibus MC, Sordi A, Cantarella D, Calogero R, Bussolati B, Tetta C and Camussi G: Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J Cell Mol Med. 14:1605–1618. 2010. View Article : Google Scholar : PubMed/NCBI